Sartorius Aktiengesellschaft (BIT:1SRT3)

Market Cap	14.56B -15.0%
Revenue (ttm)	3.52B +5.8%
Net Income	133.60M +72.2%
EPS	n/a
Shares Out	n/a
PE Ratio	109.00
Forward PE	37.29
Dividend	0.74 (0.32%)
Ex-Dividend Date	Mar 27, 2026

Volume	n/a
Average Volume	26
Open	n/a
Previous Close	234.30
Day's Range	n/a
52-Week Range	176.85 - 264.60
Beta	n/a
RSI	39.30
Earnings Date	Feb 3, 2026

About BIT:1SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,878
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SRT3

Financial Performance

In 2024, BIT:1SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.